208
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Capsule Thickness, Not Biofilm Formation, Gives Rise to Mucoid Acinetobacter baumannii Phenotypes That are More Prevalent in Long-Term Infections: A Study of Clinical Isolates from a Hospital in China

, , , , ORCID Icon, , , ORCID Icon, , & show all
Pages 99-109 | Published online: 09 Jan 2020

References

  • Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358:1271–1281. doi:10.1056/NEJMra07074118354105
  • McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013;37:130–155. doi:10.1111/j.1574-6976.2012.00344.x22568581
  • Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008;8:751–762. doi:10.1016/S1473-3099(08)70279-219022191
  • Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother. 2014;15:1351–1370. doi:10.1517/14656566.2014.91417224766095
  • Sousa AM, Pereira MO. Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs-a review. Pathogens. 2014;3(3):680–703. doi:10.3390/pathogens303068025438018
  • Wiens JR, Vasil AI, Schurr MJ, Vasil ML. Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa. mBio. 2014;5(1):e01010–13. doi:10.1128/mBio.01010-1324496793
  • Germoni LAP, Bremer PJ, Lamont IL. The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms. J Appl Microbiol. 2016;121:126–135. doi:10.1111/jam.2016.121.issue-127061817
  • Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut. 2002;50:420–424. doi:10.1136/gut.50.3.42011839725
  • Kenyon JJ, Hall RM. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS One. 2013;8:e62160. doi:10.1371/journal.pone.006216023614028
  • Geisinger E, Isberg RR. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog. 2015;11(2):e1004691. doi:10.1371/journal.ppat.100469125679516
  • Tipton KA, Chin C-Y, Farokhyfar M, Weiss DS, Rather PN. Role of capsule in resistance to disinfectants, host antimicrobials, and desiccation in acinetobacter baumannii. Antimicrob Agents Chemother. 2018;62.
  • Hua X, Zhou Z, Yang Q, et al. Evolution of Acinetobacter baumannii in vivo: international clone II, more resistance to ceftazidime, mutation in ptk. Front Microbiol. 2017;8(1256). doi:10.3389/fmicb.2017.01256
  • Zhou H, Zhang T, Yu D, et al. Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother. 2011;55:4506–4512. doi:10.1128/AAC.01134-1021788470
  • Higgins PG, Prior K, Harmsen D, Seifert H. Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS One. 2017;12(6):e0179228. doi:10.1371/journal.pone.017922828594944
  • Team R. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2015.
  • Lee HW, Koh YM, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Inf. 2008;14:49–54. doi:10.1111/j.1469-0691.2007.01842.x
  • Blum G, Hörtnagl C, Jukic E, et al. New insight into amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother. 2013;57:1583–1588. doi:10.1128/AAC.01283-1223318794
  • Kempf M, Eveillard M, Deshayes C, et al. Cell surface properties of two differently virulent strains of Acinetobacter baumannii isolated from a patient. Can J Microbiol. 2012;58:311–317. doi:10.1139/w11-13122356530
  • Chen Z, Kong H. Mucoid-type Acinetobacter baumannii was detected from the sputum of the old chronic bronchitis. Shanghai Med Lab. 1998;1:6.
  • Min KB, Lee K-M, Oh YT, Yoon SS. Nonmucoid conversion of mucoid Pseudomonas aeruginosa induced by sulfate-stimulated growth. FEMS Microbiol Lett. 2014;360:157–166. doi:10.1111/fml.2014.360.issue-225227776
  • Tuchscherr L, Medina E, Hussain M, et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med. 2011;3:129–141. doi:10.1002/emmm.v3.321268281
  • Ning NZ, Liu X, Bao CM, et al. Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China. BMC Infect Dis. 2017;17:14. doi:10.1186/s12879-016-2110-128056839
  • Jacobs AC, Thompson MG, Black CC, et al. AB5075, a highly virulent isolate of acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio. 2014;5(3):e01076–14. doi:10.1128/mBio.01076-1424865555